Found 34 hits Enz. Inhib. hit(s) with all data for entry = 50022100 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231610
![PNG](/data/jpeg/tenK5023/BindingDB_50231610.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-3-(4-(4...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccc(F)cc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H33F7N2O2/c1-26(2,40)27(25(39)37-17-18-13-21(28(31,32)33)15-22(14-18)29(34,35)36)10-7-24(16-27)38-11-8-20(9-12-38)19-3-5-23(30)6-4-19/h3-6,13-15,20,24,40H,7-12,16-17H2,1-2H3,(H,37,39)/t24-,27-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231615
![PNG](/data/jpeg/tenK5023/BindingDB_50231615.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-isopr...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(6-3-23(12-25)37-7-4-19(5-8-37)20-14-34-16-35-15-20)24(38)36-13-18-9-21(26(28,29)30)11-22(10-18)27(31,32)33/h9-11,14-17,19,23H,3-8,12-13H2,1-2H3,(H,36,38)/t23-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 receptor in human monocytes assessed as inhibition of MCP1-mediated chemotaxis |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231619
![PNG](/data/jpeg/tenK5023/BindingDB_50231619.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-(2-hy...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O2/c1-24(2,39)25(6-3-22(12-25)37-7-4-18(5-8-37)19-14-34-16-35-15-19)23(38)36-13-17-9-20(26(28,29)30)11-21(10-17)27(31,32)33/h9-11,14-16,18,22,39H,3-8,12-13H2,1-2H3,(H,36,38)/t22-,25-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 receptor in human monocytes assessed as inhibition of MCP1-mediated chemotaxis |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231620
![PNG](/data/jpeg/tenK5023/BindingDB_50231620.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-3-(4-(4...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccc(F)cc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H33F7N2O/c1-18(2)27(26(39)37-17-19-13-22(28(31,32)33)15-23(14-19)29(34,35)36)10-7-25(16-27)38-11-8-21(9-12-38)20-3-5-24(30)6-4-20/h3-6,13-15,18,21,25H,7-12,16-17H2,1-2H3,(H,37,39)/t25-,27+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231613
![PNG](/data/jpeg/tenK5023/BindingDB_50231613.png) (CHEMBL258246 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(F)c1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H33F7N2O/c1-18(2)27(26(39)37-17-19-12-22(28(31,32)33)15-23(13-19)29(34,35)36)9-6-25(16-27)38-10-7-20(8-11-38)21-4-3-5-24(30)14-21/h3-5,12-15,18,20,25H,6-11,16-17H2,1-2H3,(H,37,39)/t25-,27+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231615
![PNG](/data/jpeg/tenK5023/BindingDB_50231615.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-isopr...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(6-3-23(12-25)37-7-4-19(5-8-37)20-14-34-16-35-15-20)24(38)36-13-18-9-21(26(28,29)30)11-22(10-18)27(31,32)33/h9-11,14-17,19,23H,3-8,12-13H2,1-2H3,(H,36,38)/t23-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231615
![PNG](/data/jpeg/tenK5023/BindingDB_50231615.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-isopr...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(6-3-23(12-25)37-7-4-19(5-8-37)20-14-34-16-35-15-20)24(38)36-13-18-9-21(26(28,29)30)11-22(10-18)27(31,32)33/h9-11,14-17,19,23H,3-8,12-13H2,1-2H3,(H,36,38)/t23-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231614
![PNG](/data/jpeg/tenK5023/BindingDB_50231614.png) (CHEMBL403033 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES COc1cccc(c1)C1CCN(CC1)[C@@H]1CC[C@](C1)(C(C)C)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H36F6N2O2/c1-19(2)28(27(39)37-18-20-13-23(29(31,32)33)16-24(14-20)30(34,35)36)10-7-25(17-28)38-11-8-21(9-12-38)22-5-4-6-26(15-22)40-3/h4-6,13-16,19,21,25H,7-12,17-18H2,1-3H3,(H,37,39)/t25-,28+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231611
![PNG](/data/jpeg/tenK5023/BindingDB_50231611.png) (CHEMBL255312 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(O)c1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H34F6N2O2/c1-18(2)27(26(39)36-17-19-12-22(28(30,31)32)15-23(13-19)29(33,34)35)9-6-24(16-27)37-10-7-20(8-11-37)21-4-3-5-25(38)14-21/h3-5,12-15,18,20,24,38H,6-11,16-17H2,1-2H3,(H,36,39)/t24-,27+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231612
![PNG](/data/jpeg/tenK5023/BindingDB_50231612.png) (CHEMBL255513 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C28H33F6N3O/c1-18(2)26(8-5-24(15-26)37-10-6-20(7-11-37)21-4-3-9-35-17-21)25(38)36-16-19-12-22(27(29,30)31)14-23(13-19)28(32,33)34/h3-4,9,12-14,17-18,20,24H,5-8,10-11,15-16H2,1-2H3,(H,36,38)/t24-,26+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231619
![PNG](/data/jpeg/tenK5023/BindingDB_50231619.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-(2-hy...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O2/c1-24(2,39)25(6-3-22(12-25)37-7-4-18(5-8-37)19-14-34-16-35-15-19)23(38)36-13-17-9-20(26(28,29)30)11-21(10-17)27(31,32)33/h9-11,14-16,18,22,39H,3-8,12-13H2,1-2H3,(H,36,38)/t22-,25-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231620
![PNG](/data/jpeg/tenK5023/BindingDB_50231620.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-3-(4-(4...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccc(F)cc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H33F7N2O/c1-18(2)27(26(39)37-17-19-13-22(28(31,32)33)15-23(14-19)29(34,35)36)10-7-25(16-27)38-11-8-21(9-12-38)20-3-5-24(30)6-4-20/h3-6,13-15,18,21,25H,7-12,16-17H2,1-2H3,(H,37,39)/t25-,27+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231618
![PNG](/data/jpeg/tenK5023/BindingDB_50231618.png) (CHEMBL401608 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cc(Cl)ncn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H31ClF6N4O2/c1-24(2,40)25(23(39)35-14-16-9-18(26(29,30)31)11-19(10-16)27(32,33)34)6-3-20(13-25)38-7-4-17(5-8-38)21-12-22(28)37-15-36-21/h9-12,15,17,20,40H,3-8,13-14H2,1-2H3,(H,35,39)/t20-,25-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231617
![PNG](/data/jpeg/tenK5023/BindingDB_50231617.png) (3-(1-((1R,3S)-3-((3,5-bis(trifluoromethyl)benzyl)c...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(c1)C(O)=O)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H34F6N2O3/c1-18(2)28(27(41)37-17-19-12-23(29(31,32)33)15-24(13-19)30(34,35)36)9-6-25(16-28)38-10-7-20(8-11-38)21-4-3-5-22(14-21)26(39)40/h3-5,12-15,18,20,25H,6-11,16-17H2,1-2H3,(H,37,41)(H,39,40)/t25-,28+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231617
![PNG](/data/jpeg/tenK5023/BindingDB_50231617.png) (3-(1-((1R,3S)-3-((3,5-bis(trifluoromethyl)benzyl)c...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(c1)C(O)=O)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H34F6N2O3/c1-18(2)28(27(41)37-17-19-12-23(29(31,32)33)15-24(13-19)30(34,35)36)9-6-25(16-28)38-10-7-20(8-11-38)21-4-3-5-22(14-21)26(39)40/h3-5,12-15,18,20,25H,6-11,16-17H2,1-2H3,(H,37,41)(H,39,40)/t25-,28+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231621
![PNG](/data/jpeg/tenK5023/BindingDB_50231621.png) (CHEMBL256954 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccncn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(7-3-22(14-25)37-9-5-19(6-10-37)23-4-8-34-16-36-23)24(38)35-15-18-11-20(26(28,29)30)13-21(12-18)27(31,32)33/h4,8,11-13,16-17,19,22H,3,5-7,9-10,14-15H2,1-2H3,(H,35,38)/t22-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231608
![PNG](/data/jpeg/tenK5023/BindingDB_50231608.png) (3-(1-(3-((3,5-bis(trifluoromethyl)benzyl)carbamoyl...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(c1)C(O)=O)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H34F6N2O4/c1-27(2,42)28(26(41)37-17-18-12-22(29(31,32)33)15-23(13-18)30(34,35)36)9-6-24(16-28)38-10-7-19(8-11-38)20-4-3-5-21(14-20)25(39)40/h3-5,12-15,19,24,42H,6-11,16-17H2,1-2H3,(H,37,41)(H,39,40)/t24-,28-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231613
![PNG](/data/jpeg/tenK5023/BindingDB_50231613.png) (CHEMBL258246 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(F)c1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H33F7N2O/c1-18(2)27(26(39)37-17-19-12-22(28(31,32)33)15-23(13-19)29(34,35)36)9-6-25(16-27)38-10-7-20(8-11-38)21-4-3-5-24(30)14-21/h3-5,12-15,18,20,25H,6-11,16-17H2,1-2H3,(H,37,39)/t25-,27+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231622
![PNG](/data/jpeg/tenK5023/BindingDB_50231622.png) (CHEMBL257160 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccnn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(8-5-22(15-25)37-10-6-19(7-11-37)23-4-3-9-35-36-23)24(38)34-16-18-12-20(26(28,29)30)14-21(13-18)27(31,32)33/h3-4,9,12-14,17,19,22H,5-8,10-11,15-16H2,1-2H3,(H,34,38)/t22-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231610
![PNG](/data/jpeg/tenK5023/BindingDB_50231610.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-3-(4-(4...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccc(F)cc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H33F7N2O2/c1-26(2,40)27(25(39)37-17-18-13-21(28(31,32)33)15-22(14-18)29(34,35)36)10-7-24(16-27)38-11-8-20(9-12-38)19-3-5-23(30)6-4-19/h3-6,13-15,20,24,40H,7-12,16-17H2,1-2H3,(H,37,39)/t24-,27-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231616
![PNG](/data/jpeg/tenK5023/BindingDB_50231616.png) (CHEMBL401609 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccnnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(7-3-23(14-25)37-9-5-19(6-10-37)20-4-8-35-36-16-20)24(38)34-15-18-11-21(26(28,29)30)13-22(12-18)27(31,32)33/h4,8,11-13,16-17,19,23H,3,5-7,9-10,14-15H2,1-2H3,(H,34,38)/t23-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231611
![PNG](/data/jpeg/tenK5023/BindingDB_50231611.png) (CHEMBL255312 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(O)c1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C29H34F6N2O2/c1-18(2)27(26(39)36-17-19-12-22(28(30,31)32)15-23(13-19)29(33,34)35)9-6-24(16-27)37-10-7-20(8-11-37)21-4-3-5-25(38)14-21/h3-5,12-15,18,20,24,38H,6-11,16-17H2,1-2H3,(H,36,39)/t24-,27+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231621
![PNG](/data/jpeg/tenK5023/BindingDB_50231621.png) (CHEMBL256954 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccncn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(7-3-22(14-25)37-9-5-19(6-10-37)23-4-8-34-16-36-23)24(38)35-15-18-11-20(26(28,29)30)13-21(12-18)27(31,32)33/h4,8,11-13,16-17,19,22H,3,5-7,9-10,14-15H2,1-2H3,(H,35,38)/t22-,25+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231609
![PNG](/data/jpeg/tenK5023/BindingDB_50231609.png) (CHEMBL402010 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ncccn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(7-4-22(15-25)37-10-5-19(6-11-37)23-34-8-3-9-35-23)24(38)36-16-18-12-20(26(28,29)30)14-21(13-18)27(31,32)33/h3,8-9,12-14,17,19,22H,4-7,10-11,15-16H2,1-2H3,(H,36,38)/t22-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 144 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50231623
![PNG](/data/jpeg/tenK5023/BindingDB_50231623.png) (CHEMBL257159 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1ccc(Cl)nn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H31ClF6N4O/c1-16(2)25(24(39)35-15-17-11-19(26(29,30)31)13-20(12-17)27(32,33)34)8-5-21(14-25)38-9-6-18(7-10-38)22-3-4-23(28)37-36-22/h3-4,11-13,16,18,21H,5-10,14-15H2,1-2H3,(H,35,39)/t21-,25+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 165 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 receptor in human monocytes |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231618
![PNG](/data/jpeg/tenK5023/BindingDB_50231618.png) (CHEMBL401608 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cc(Cl)ncn1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H31ClF6N4O2/c1-24(2,40)25(23(39)35-14-16-9-18(26(29,30)31)11-19(10-16)27(32,33)34)6-3-20(13-25)38-7-4-17(5-8-38)21-12-22(28)37-15-36-21/h9-12,15,17,20,40H,3-8,13-14H2,1-2H3,(H,35,39)/t20-,25-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 186 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231614
![PNG](/data/jpeg/tenK5023/BindingDB_50231614.png) (CHEMBL403033 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES COc1cccc(c1)C1CCN(CC1)[C@@H]1CC[C@](C1)(C(C)C)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H36F6N2O2/c1-19(2)28(27(39)37-18-20-13-23(29(31,32)33)16-24(14-20)30(34,35)36)10-7-25(17-28)38-11-8-21(9-12-38)22-5-4-6-26(15-22)40-3/h4-6,13-16,19,21,25H,7-12,17-18H2,1-3H3,(H,37,39)/t25-,28+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 217 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231612
![PNG](/data/jpeg/tenK5023/BindingDB_50231612.png) (CHEMBL255513 | N-(3,5-bis(trifluoromethyl)benzyl)-...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C28H33F6N3O/c1-18(2)26(8-5-24(15-26)37-10-6-20(7-11-37)21-4-3-9-35-17-21)25(38)36-16-19-12-22(27(29,30)31)14-23(13-19)28(32,33)34/h3-4,9,12-14,17-18,20,24H,5-8,10-11,15-16H2,1-2H3,(H,36,38)/t24-,26+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 224 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231617
![PNG](/data/jpeg/tenK5023/BindingDB_50231617.png) (3-(1-((1R,3S)-3-((3,5-bis(trifluoromethyl)benzyl)c...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(c1)C(O)=O)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H34F6N2O3/c1-18(2)28(27(41)37-17-19-12-23(29(31,32)33)15-24(13-19)30(34,35)36)9-6-25(16-28)38-10-7-20(8-11-38)21-4-3-5-22(14-21)26(39)40/h3-5,12-15,18,20,25H,6-11,16-17H2,1-2H3,(H,37,41)(H,39,40)/t25-,28+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231617
![PNG](/data/jpeg/tenK5023/BindingDB_50231617.png) (3-(1-((1R,3S)-3-((3,5-bis(trifluoromethyl)benzyl)c...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(c1)C(O)=O)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H34F6N2O3/c1-18(2)28(27(41)37-17-19-12-23(29(31,32)33)15-24(13-19)30(34,35)36)9-6-25(16-28)38-10-7-20(8-11-38)21-4-3-5-22(14-21)26(39)40/h3-5,12-15,18,20,25H,6-11,16-17H2,1-2H3,(H,37,41)(H,39,40)/t25-,28+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231619
![PNG](/data/jpeg/tenK5023/BindingDB_50231619.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-(2-hy...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O2/c1-24(2,39)25(6-3-22(12-25)37-7-4-18(5-8-37)19-14-34-16-35-15-19)23(38)36-13-17-9-20(26(28,29)30)11-21(10-17)27(31,32)33/h9-11,14-16,18,22,39H,3-8,12-13H2,1-2H3,(H,36,38)/t22-,25-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 844 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231615
![PNG](/data/jpeg/tenK5023/BindingDB_50231615.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-isopr...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(6-3-23(12-25)37-7-4-19(5-8-37)20-14-34-16-35-15-20)24(38)36-13-18-9-21(26(28,29)30)11-22(10-18)27(31,32)33/h9-11,14-17,19,23H,3-8,12-13H2,1-2H3,(H,36,38)/t23-,25+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231615
![PNG](/data/jpeg/tenK5023/BindingDB_50231615.png) ((1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-1-isopr...)Show SMILES CC(C)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cncnc1)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C27H32F6N4O/c1-17(2)25(6-3-23(12-25)37-7-4-19(5-8-37)20-14-34-16-35-15-20)24(38)36-13-18-9-21(26(28,29)30)11-22(10-18)27(31,32)33/h9-11,14-17,19,23H,3-8,12-13H2,1-2H3,(H,36,38)/t23-,25+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50231608
![PNG](/data/jpeg/tenK5023/BindingDB_50231608.png) (3-(1-(3-((3,5-bis(trifluoromethyl)benzyl)carbamoyl...)Show SMILES CC(C)(O)[C@@]1(CC[C@H](C1)N1CCC(CC1)c1cccc(c1)C(O)=O)C(=O)NCc1cc(cc(c1)C(F)(F)F)C(F)(F)F Show InChI InChI=1S/C30H34F6N2O4/c1-27(2,42)28(26(41)37-17-18-12-22(29(31,32)33)15-23(13-18)30(34,35)36)9-6-24(16-28)38-10-7-19(8-11-38)20-4-3-5-21(14-20)25(39)40/h3-5,12-15,19,24,42H,6-11,16-17H2,1-2H3,(H,37,41)(H,39,40)/t24-,28-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.97E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [33S]MK499 from human ERG expressed in HEK cells |
Bioorg Med Chem Lett 18: 994-8 (2008)
Article DOI: 10.1016/j.bmcl.2007.12.029 BindingDB Entry DOI: 10.7270/Q2SQ9046 |
More data for this Ligand-Target Pair | |